.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Covington
Cerilliant
Novartis
McKinsey
Chinese Patent Office
Fuji
QuintilesIMS
AstraZeneca

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Pulsed drug delivery of doxylamine
Abstract:A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
Inventor(s): Ayer; Atul D. (Mountain View, CA), Theeuwes; Felix (Los Altos, CA), Wong; Patrick S. (Hayward, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Filing Date:May 09, 1986
Application Number:06/861,188
Claims:1. A single dosage form comprising two doses of a beneficial drug formulation useful as a sleep-aid for administering to a recipient, said dosage form comprising:

(a) a dosage amount of a first dose of a doxylamine formulation coated on the exterior surface of the dosage form;

(b) a first wall comprising in at least a part a semipermeable composition permeable to the passage of fluid, said wall surrounding;

(c) a second wall comprising means for delaying release of a doxylamine formulation from the interior of the dosage form, said second wall surrounding;

(d) a first layer comprising a second dose of a doxylamine formulation;

(e) a second layer comprising a hydrophilic hydrogel formulation that swells in the presence of fluid; and,

(f) at least one exit means in the wall for releasing doxylamine formulation from the interior of the dosage form.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Deloitte
AstraZeneca
Cerilliant
US Department of Justice
Medtronic
McKinsey
Baxter
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot